What should you know about prostate cancer clinical trials?

A trial may study a medicine, radiation approach, surgery, diagnostic method, symptom treatment or combination of care. The protocol sets out who can join, what visits and tests are needed, and how outcomes or side effects are monitored. Some trials compare approaches; others examine a single option. Being invited to discuss a trial does not mean you must enrol, and eligibility is not the same as a promise of benefit.

Ask the study team for the written consent information and a clear visit schedule. Review the treatment being tested, possible side effects, other available options, extra tests, travel needs and who pays for trial-related care. Tell the team about previous treatments, other illnesses and medicines. Take time to discuss the choice with people you trust; you can ask whether leaving the trial would affect your usual care.

Contact the trial team promptly about new or worsening symptoms, even if they seem unrelated. Fever, breathing difficulty, severe pain, confusion, heavy bleeding or inability to pass urine may need urgent medical care. Keep the emergency contact details supplied by the study team and do not stop a trial medicine without instructions unless emergency clinicians advise it.

Ask what the trial is designed to learn, why you may qualify, how assignment is made, what the comparison care is, and which visits are essential. Clarify side-effect monitoring, contraception or fertility considerations, data privacy, withdrawal arrangements and the plan after the trial ends.